Latest Regulatory News

ALS Limited has completed a significant institutional placement, issuing over 20.9 million shares at A$16.70 each, bolstering its capital base without the need for full disclosure under the Corporations Act.

Cash Converters has secured a £12 million growth facility from Lloyds Bank and agreed to acquire 10 UK franchise stores, marking a significant step in its UK expansion strategy.

Ballard Mining Limited is set to raise $25-$30 million through an IPO to advance the Mt Ida Gold Project, boasting a 1.1 million ounce resource and significant exploration upside. The move follows a strategic demerger from Delta Lithium, positioning Ballard as a focused gold developer with an experienced leadership team.

Ballard Mining Limited is launching an IPO to raise up to $30 million, aiming to accelerate exploration and development of its Mt Ida Gold Project in Western Australia, which hosts over 1.1 million ounces of gold.

Delta Lithium Limited has announced a proposed demerger involving an in-specie distribution of over 63 million Ballard Mining shares to eligible shareholders, pending approval at a June 30 meeting. This move will reduce Delta's stake in Ballard and set the stage for Ballard's eventual ASX listing.

Otto Energy Limited has clarified that part of its recent capital return will be treated as a dividend according to a draft ATO ruling, prompting shareholders to consider tax implications carefully.

Betashares Capital Ltd has announced the final distribution amounts for May 2025 for a suite of 16 ETFs listed on the ASX AQUA market, all franked and eligible for reinvestment via the Distribution Reinvestment Plan.

Credit Intelligence Ltd has announced a conditional agreement to sell its loss-making subsidiary Credit Intelligence Holding Limited for AUD 1.5 million, pending shareholder approval and regulatory clearances.

Helios Energy Limited has come under ASX compliance scrutiny after late lodgement of director interest notices, raising questions about its disclosure practices and governance.

Sky Metals has expanded the high-grade tin zone at its Tallebung project in NSW, reporting strong initial drilling results that have prompted a major increase in its exploration program.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Mount Hope Mining Limited has announced a non-renounceable pro-rata Loyalty Option Offer to raise approximately $103,125, aiming to bolster exploration funding and reward shareholder loyalty.